Search of chemical scaffolds for novel antituberculosis agents
- PMID: 15809316
- DOI: 10.1177/1087057104273486
Search of chemical scaffolds for novel antituberculosis agents
Abstract
A method to identify chemical scaffolds potentially active against Mycobacterium tuberculosis is presented. The molecular features of a set of structurally heterogeneous antituberculosis drugs were coded by means of structural invariants. Three techniques were used to obtain equations able to model the antituberculosis activity: linear discriminant analysis, multilinear regression, and shrinkage estimation-ridge regression. The model obtained was statistically validated through leave-n-out test, and an external set and was applied to a database for the search of new active agents. The selected compounds were assayed in vitro, and among those identified as active stand reserpine, N,N,N',N'-tetrakis-(2-pyridylmethyl)-ethylenediamine (TPEN), trifluoperazine, pentamidine, and 2-methyl-4,6-dinitro-phenol (DNOC). They show activity comparable to or superior to ethambutol, used in combination with other drugs for the prevention and treatment of Mycobacterium avium complex and drug-resistant tuberculosis.
Similar articles
-
New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method.J Antimicrob Chemother. 2004 Jan;53(1):65-73. doi: 10.1093/jac/dkh014. Epub 2003 Nov 25. J Antimicrob Chemother. 2004. PMID: 14645324
-
Global Bayesian models for the prioritization of antitubercular agents.J Chem Inf Model. 2008 Dec;48(12):2362-70. doi: 10.1021/ci800143n. J Chem Inf Model. 2008. PMID: 19053518
-
QSAR modeling of a set of pyrazinoate esters as antituberculosis prodrugs.Arch Pharm (Weinheim). 2010 Feb;343(2):91-7. doi: 10.1002/ardp.200900216. Arch Pharm (Weinheim). 2010. PMID: 20099263
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Current pharmaceutical design of antituberculosis drugs: future perspectives.Curr Pharm Des. 2010;16(24):2656-65. doi: 10.2174/138161210792389289. Curr Pharm Des. 2010. PMID: 20642433 Review.
Cited by
-
Enhancing hit identification in Mycobacterium tuberculosis drug discovery using validated dual-event Bayesian models.PLoS One. 2013 May 7;8(5):e63240. doi: 10.1371/journal.pone.0063240. Print 2013. PLoS One. 2013. PMID: 23667592 Free PMC article.
-
Application of Quantitative Structure-Activity Relationships in the Prediction of New Compounds with Anti-Leukemic Activity.Int J Mol Sci. 2023 Jul 31;24(15):12258. doi: 10.3390/ijms241512258. Int J Mol Sci. 2023. PMID: 37569634 Free PMC article.
-
Study of peptide fingerprints of parasite proteins and drug-DNA interactions with Markov-Mean-Energy invariants of biopolymer molecular-dynamic lattice networks.Polymer (Guildf). 2009 Jul 17;50(15):3857-3870. doi: 10.1016/j.polymer.2009.05.055. Epub 2009 Jun 3. Polymer (Guildf). 2009. PMID: 32287404 Free PMC article.
-
Design of novel antituberculosis compounds using graph-theoretical and substructural approaches.Mol Divers. 2009 Nov;13(4):445-58. doi: 10.1007/s11030-009-9129-9. Epub 2009 Apr 2. Mol Divers. 2009. PMID: 19340599
-
True prediction of lowest observed adverse effect levels.Mol Divers. 2006 May;10(2):159-68. doi: 10.1007/s11030-005-9007-z. Epub 2006 May 24. Mol Divers. 2006. PMID: 16721628
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources